Board Meetings for ROSSARI

Detailed list of historic and upcoming board meetings.

SymbolCompanyMeeting DatePurposeDescriptionLinks
ROSSARIRossari Biotech Limited14 Feb 2022Financial ResultsBoard Meeting intimation to consider and approve Unaudited Financial Results (Standalone and Consolidated) for the quarter and nine months ended December 31, 2021
ROSSARIRossari Biotech Limited29 Jan 2022Board meeting RescheduledRossari Biotech Limited has informed the Exchange that the meeting of the Board of Directors of the Company scheduled to be held on January 29, 2022 has been postponed due to unavoidable circumstances.
ROSSARIRossari Biotech Limited29 Jan 2022Financial ResultsBoard Meeting intimation to consider and approve Unaudited Financial Results (Standalone and Consolidated) for the quarter and nine months ended December 31, 2021
ROSSARIRossari Biotech Limited30 Oct 2021Financial ResultsBoard Meeting intimation to consider and approve Unaudited Financial Results (Standalone and Consolidated) for the quarter ended September 30, 2021.
ROSSARIRossari Biotech Limited30 Jul 2021Financial Resultsinter alia, to consider and approve the Un-audited financial results (Standalone and Consolidated) for the period ended Jun 30, 2021
ROSSARIRossari Biotech Limited14 May 2021Financial Results/DividendMeeting Board of Directors of the Company is scheduled to be held on Friday, May 14, 2021,inter alia, To consider and approve the financial results for the period ended March 31, 2021 and recommend payment of Final Dividend, if any, for the financial year ended March 31, 2021.
ROSSARIRossari Biotech Limited23 Mar 2021Fund RaisingTo consider Fund Raising
ROSSARIRossari Biotech Limited23 Jan 2021Financial ResultsTo consider and approve the financial results for the quarter and nine months ended December 31, 2020
ROSSARIRossari Biotech Limited24 Oct 2020Financial ResultsTo consider and approve the financial results for the period ended September 30, 2020
ROSSARIRossari Biotech Limited21 Aug 2020Financial ResultsTo consider and approve the financial results for the period ended Jun 30, 2020
Showing page 3 of 3 (40 total items)